how many people are taking glp 1 drugs Chart: in 8 Americans Now Use GLP-1 for Weight Loss Market Overview: GLP-1 Agonists and
Description
About 2.7 million Americans currently take Lillys injectable Zepbound, it said
Wegovy users keep weight off for nearly four years: Study Clinical trial data on the GLP-1 agonist drug Wegovy showed sustained weight loss for up to four years after starting the medication
Researchers dont know exactly why some people dont respond
Funding This study was not supported by any sponsor or funder
This condition can trigger numerous uncomfortable symptoms, such as: Queasiness Throwing up Premature fullness after consuming minimal food Stomach bloating or discomfort Reduced appetite Acid reflux Extended sensation of fullness following meals The severity of these symptoms varies from minor to intense, and they may substantially interfere with everyday activities in certain situations
